Those mice that underwent this therapeutic approach had obviously higher infiltration of tumor by means of blastic and activated CD4+T and CD8+ lymphocytes that included perforin/granzyme B and expressed ISmAb-targeted receptors on their surface (Morales-Kastresana et al., 2013[67]). This evidence concerns the gene CD4 and neoplasm.